KRAS and infection: While the NS3-NS4B interaction blocking mechanism of action of this novel antiviral was previously established [43], robustly quantifying the effect of the antiviral on viral dynamics both in-vivo and across different host systems is critical to developing an understanding of the potential impact of antiviral treatment for infection and disease control.